BBR Partners LLC lifted its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,296 shares of the company’s stock after acquiring an additional 186 shares during the period. BBR Partners LLC’s holdings in Procter & Gamble were worth $1,610,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in PG. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble during the 2nd quarter worth $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble in the second quarter worth about $29,000. RPg Family Wealth Advisory LLC acquired a new position in Procter & Gamble during the third quarter worth about $33,000. POM Investment Strategies LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at about $34,000. Finally, Quest Partners LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at about $36,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Procter & Gamble
In other news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 35,233 shares of company stock worth $6,024,234. Company insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.83 earnings per share. As a group, analysts anticipate that The Procter & Gamble Company will post 6.96 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.24%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.
Analyst Ratings Changes
PG has been the subject of a number of analyst reports. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. JPMorgan Chase & Co. upped their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. DA Davidson upgraded Procter & Gamble from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $160.00 to $209.00 in a report on Monday. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Finally, Wells Fargo & Company raised their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $180.45.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Ride Out The Recession With These Dividend KingsĀ
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Invest in the FAANG Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- Basic Materials Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.